Relating to authorizing the Board of Pharmacy to promulgate a legislative rule relating to inspections.

2026 Regular Session Introduced by Doug Smith

Gives the Board of Pharmacy authority to adopt a formal rule governing inspections to standardize how inspections are conducted.

To House Judiciary

#legislature--rulemaking

Bill Summary: HB 4314 (West Virginia, 2026)

Purpose and intent

Establishes authority for the West Virginia Board of Pharmacy to promulgate a legislative rule governing inspections.

The bill aims to formalize and codify inspection procedures carried out by or under the authority of the Board of Pharmacy, ensuring a standardized regulatory framework for pharmacy inspections in the state.

Key provisions and changes

Authorizes the Board of Pharmacy to promulgate a legislative rule specifically related to inspections. This likely covers aspects such as:

Scope of inspections (which facilities or activities are subject)
Scheduling and notification requirements
Inspection standards, protocols, and criteria
Compliance expectations and actions for violations
Documentation, reporting, and recordkeeping requirements
Penalties or enforcement mechanisms for noncompliance (subject to established Board rules)

The rulemaking authority is limited to inspections and does not appear to grant broader regulatory powers beyond inspection-related provisions unless implied by the rule content.

The bill does not provide the full text of the rule but sets the legislative permission for the Board to adopt such rules.

Who would be affected

Primary: Licensed and regulated entities under the West Virginia Board of Pharmacy, including:

Community and hospital pharmacies
Wholesale/ distributor facilities
Pharmacy technicians and other personnel subject to inspection regimes
Any facility or operation overseen by the Board of Pharmacy that falls within inspection purview

State regulatory staff and Board of Pharmacy personnel responsible for conducting inspections and enforcing the rule.

Procedural and timeline aspects

Action history indicates the bill progressed as follows:

Filed for introduction on January 14, 2026
Initial referrals: Government Organization, then Judiciary
House committees: Government Organization, then Judiciary
Committee report: “Do pass, but first to Judiciary” on January 30, 2026

This suggests the bill is moving through the standard committee process and has received committee support, with a recommendation to advance to the full chamber for consideration.

As a proposed rulemaking authorization, the actual substantive protections, standards, and penalties would be detailed in the legislative rule adopted by the Board of Pharmacy subsequent to legislative approval.

Potential impact and considerations

Potential benefits:

Creates a clear, codified framework for how inspections are conducted, which can improve consistency and transparency.
Helps licensees understand inspection expectations and compliance standards.
Supports enforcement integrity by aligning inspections with formal, board-approved rules.

Potential considerations:

The bill’s effectiveness depends on the specifics of the rule adopted by the Board; those details will determine inspection frequency, parameters, and penalties.
Stakeholders may seek clarity on how inspections interact with existing licensure processes, confidentiality, and due process rights during enforcement.
Implementation timing will hinge on the Board’s rulemaking timeline after legislative approval.

If you’d like, I can provide a brief appendix outlining typical elements found in Board of Pharmacy inspection rules to contextualize what standards and processes might appear in the forthcoming rule.